NCT06466031 - Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme | Biotech Hunter

Enrollment

189

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2032

Conditions

Glioblastoma Multiforme

Interventions

OTHER

MRI & PET fusion

MRI+T1C in fusion with MET-PET will be used for tumor resection and/or radiotherapy planning. Resection will be terminated after removal of PET-assigned tumor margin or in case any neuromonitoring-based indications regarding neurological damage occur.

OTHER

MRI+T1C

MRI+T1C will be used for tumor resection and radiotherapy planning. Resection will be terminated after removal of contrast-enhancing part regardless of 5-ALA fluorescence or in case any neuromonitoring-based indications regarding neurological damage occur.

Trial Locations (1)

93-513

Copernicus Memorial Hospital in Łódź, Poland, Lodz